Development
NeuroOne Medical Technologies Corporation
NMTC
$0.5817
-$0.0073-1.24%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 2.82M | 3.41M | 4.68M | 4.08M | 3.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.82M | 3.41M | 4.68M | 4.08M | 3.65M |
| Cost of Revenue | 8.94M | 8.44M | 7.63M | 6.62M | 5.75M |
| Gross Profit | -6.13M | -5.03M | -2.95M | -2.54M | -2.10M |
| SG&A Expenses | 7.44M | 6.93M | 7.24M | 6.90M | 6.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.38M | 15.36M | 14.87M | 13.52M | 12.66M |
| Operating Income | -13.56M | -11.96M | -10.19M | -9.44M | -9.01M |
| Income Before Tax | -13.47M | -11.86M | -10.10M | -9.39M | -8.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.47 | -11.86 | -10.10 | -9.39 | -8.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.47M | -11.86M | -10.10M | -9.39M | -8.92M |
| EBIT | -13.56M | -11.96M | -10.19M | -9.44M | -9.01M |
| EBITDA | -13.34M | -11.76M | -10.02M | -9.30M | -8.88M |
| EPS Basic | -0.69 | -0.66 | -0.60 | -0.58 | -0.55 |
| Normalized Basic EPS | -0.43 | -0.41 | -0.37 | -0.36 | -0.34 |
| EPS Diluted | -0.69 | -0.66 | -0.60 | -0.58 | -0.55 |
| Normalized Diluted EPS | -0.43 | -0.41 | -0.37 | -0.36 | -0.34 |
| Average Basic Shares Outstanding | 80.25M | 72.49M | 66.44M | 65.05M | 64.83M |
| Average Diluted Shares Outstanding | 80.25M | 72.49M | 66.44M | 65.05M | 64.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |